01 1Navinta
01 1SODIUM PHENYLBUTYRATE USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-03-04
Pay. Date : 2025-02-20
DMF Number : 40965
Submission : 2025-02-24
Status : Active
Type : II
20
Navinta Llc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SODIUM PHENYLBUTYRATE USP, with a corresponding US DMF Number 40965.
Remarkably, this DMF maintains an Active status since its submission on February 24, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 04, 2025, and payment made on February 20, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
